Blue Cross and Blue Shield of North Carolina does not cover Wegovy as a standard benefit on its commercial plans, so for most members the answer to “does BCBSNC cover Wegovy” is no. The drug sits on the insurer’s list of weight-loss medications excluded from standard coverage, which means a prior authorization will not open the door the way it does for many other drugs. A few narrow pathways exist, mostly tied to self-funded employer plans and, for Medicare members, a new federal program starting in mid-2026.
Why Standard Plans Exclude Wegovy
Blue Cross NC’s formulary categorizes Wegovy, along with Zepbound, Saxenda, Contrave, and Qsymia, as “not covered as a standard benefit.”1Blue Cross NC. Non-Formulary Drugs The marketplace formulary documents reinforce this, noting that “coverage of drugs used for weight loss may be subject to benefit exclusion based on member benefit.”2MyPrime. Blue Cross NC Essential QHP-S 4-Tier Formulary
The distinction matters. A prior authorization requirement means the drug is covered if you meet clinical criteria. A benefit exclusion means the plan does not pay for the drug at all, no matter how clearly you qualify medically. The list price for a 28-day supply of Wegovy runs roughly $1,350, or about $16,200 per year.3GoodRx. Wegovy for Weight Loss Cost and Coverage
The One Commercial Exception: Self-Funded Employer Plans With Vida
Effective January 1, 2025, Blue Cross NC introduced a “GLP-1 for Weight Management” program powered by Vida Health. It is available only to Administrative Services Only plans, meaning self-funded employer plans where Blue Cross NC administers benefits but the employer decides what to cover.4Blue Cross NC. New Expanded Member Programs
To qualify, members must meet the FDA-approved clinical criteria for anti-obesity medication: a BMI of 30 or above without weight-related comorbidities, or a BMI of 27 or above with weight-related comorbidities such as high blood pressure, high cholesterol, or type 2 diabetes. Members must also be enrolled in a Blue Cross NC pharmacy plan. The program pairs the medication with a registered-dietitian-led coaching program covering nutrition, physical activity, and self-monitoring. Members already taking a GLP-1 can have the remainder of an existing prior authorization honored if they enroll.4Blue Cross NC. New Expanded Member Programs
Whether a given employer has opted in varies plan by plan. Call the number on the back of your member ID card to confirm.
Medicare Advantage Members and the GLP-1 Bridge
Standard Medicare Part D does not cover weight-loss drugs, and Blue Cross NC’s 2026 Medicare Advantage formulary does not list Wegovy.5Blue Cross NC. Blue Medicare Choice HMO Formulary A separate federal pathway opens on July 1, 2026, when the Medicare GLP-1 Bridge launches.
The Bridge is a temporary CMS program providing access to Wegovy (injection and tablet), Zepbound (KwikPen), and Foundayo outside the normal Part D benefit. Anyone enrolled in a Part D plan or a Medicare Advantage prescription drug plan is eligible, including Blue Cross NC Medicare members. The program runs through December 31, 2027.6CMS. Medicare GLP-1 Bridge
Eligibility uses tiered BMI and health criteria:
- BMI of 35 or higher, with no additional diagnosis required.
- BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease (stage 3a or above).
- BMI of 27 or higher with pre-diabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.
Participants pay a flat $50 copay per 30-day supply. That copay does not count toward the Part D deductible or out-of-pocket maximum, and Extra Help subsidies cannot reduce it.7Medicare.gov. Weight Loss Drugs The prior authorization goes through a central processor (Humana handles Bridge claims) rather than the member’s Part D plan.8CMS. Medicare GLP-1 Bridge Information for Providers
A Note for State Employees and Retirees
The North Carolina State Health Plan is a separate program from Blue Cross NC commercial insurance, even though Blue Cross NC administers it. The State Health Plan covered Wegovy and other GLP-1 weight-loss drugs until the Board of Trustees voted in January 2024 to end coverage, effective April 1, 2024.9WRAL. NC State Health Plan Phases Out Weight-Loss Drug Coverage As of mid-2026, weight-loss coverage has not been restored, though the plan continues to cover GLP-1 drugs prescribed for diabetes. State Treasurer Brad Briner has said the upcoming state budget is unlikely to include the roughly $100 million needed to bring back the benefit, though the plan is negotiating directly with manufacturers.10WRAL. North Carolina Expected Budget Won’t Restore Weight-Loss Coverage
What To Do if Your Plan Won’t Cover Wegovy
Confirm What Your Specific Plan Does
Coverage varies by plan design, especially on the employer side. Call the member services number on the back of your ID card and ask directly whether your plan covers Wegovy or any GLP-1 for weight management, and whether your employer has opted into the Vida program.
File an Appeal
If your plan has a pathway to coverage and your claim was denied, you or your prescriber can appeal. Review the Explanation of Benefits for the specific reason for denial, then submit a written appeal within six months of the denial notice. Useful documentation includes your current BMI, the history of prior weight-loss treatments that did not work, your weight-related health conditions, and a statement from your provider on medical necessity. About 44% of insurance denials are successfully appealed, according to 2023 data.11Medical News Today. How To Appeal a Wegovy Denial
One angle worth considering: even plans that exclude weight-loss drugs may cover Wegovy under its separate FDA-approved indication for reducing the risk of major cardiovascular events in adults with established heart disease and obesity or overweight. An appeal framed around cardiovascular risk reduction rather than weight loss may be reviewed differently.12Novo Nordisk. Wegovy Denials and Appeals Guide
Ask Your Employer To Add the Benefit
If you’re on an employer-sponsored plan, especially a self-funded one, the employer can choose to add anti-obesity medication coverage. Novo Nordisk publishes a sample letter a provider can submit to a benefits department making the case.13Wegovy. What To Pay for Wegovy
If You End Up Paying Out of Pocket
Several options bring the cost below the full list price:
- Patients with commercial insurance that doesn’t cover Wegovy may be able to use a Novo Nordisk copay card to pay as little as $25 per month, with maximum savings of $100 per month. Government-plan beneficiaries are not eligible.13Wegovy. What To Pay for Wegovy
- For uninsured or self-pay patients, Novo Nordisk offers the 1.5 mg and 4 mg doses at $149 per month through August 31, 2026 (the 4 mg dose rises to $199 after that). New patients starting on lower doses can get an introductory rate of $199 per month for the first two months, and the standard self-pay price for injections after introductory periods is $349 per month.14NovoCare. Savings and Support
- Several telehealth providers offer subscription pricing for the oral Wegovy tablet, ranging from $249 to $289 per month depending on commitment length.15Drugs.com. Wegovy Covered by Insurance
- Uninsured patients with household income at or below 400% of the federal poverty level may qualify for the Novo Nordisk Patient Assistance Program, which provides the medication at no cost. Applicants must be U.S. citizens or legal residents and cannot have private insurance or qualify for Medicaid or VA benefits.16NovoCare. Patient Assistance Program
- HSA and FSA funds can generally be applied to weight-loss medications, letting you pay with pre-tax dollars.
For questions about savings offers, Novo Nordisk’s support line is 1-888-793-1218.13Wegovy. What To Pay for Wegovy